These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26015192)

  • 1. [Heart risk due to testosterone?].
    Grätzel P
    MMW Fortschr Med; 2015 Apr; 157(6):27. PubMed ID: 26015192
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Testosterone Products: Drug Safety Communication - FDA Cautions about Using Testosterone Products for Low Testosterone due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack and Stroke.
    Seftel AD
    J Urol; 2015 Sep; 194(3):759-60. PubMed ID: 26292880
    [No Abstract]   [Full Text] [Related]  

  • 3. Testosterone: myocardial infarction and stroke.
    Prescrire Int; 2014 Oct; 23(153):240-1. PubMed ID: 25964971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone replacement therapy faces FDA scrutiny.
    Garnick MB
    JAMA; 2015 Feb; 313(6):563-4. PubMed ID: 25502018
    [No Abstract]   [Full Text] [Related]  

  • 5. [Testosterone supplementation: good feeling in the pants, pain in the chest].
    Einecke D
    MMW Fortschr Med; 2014 Mar; 156(4):22. PubMed ID: 24908760
    [No Abstract]   [Full Text] [Related]  

  • 6. A new testosterone gel (fortesta) for hypogonadism.
    Med Lett Drugs Ther; 2011 Apr; 53(1362):29-30. PubMed ID: 21502933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The testosterone storm.
    Gomella LG
    Can J Urol; 2015 Apr; 22(2):7677. PubMed ID: 25891328
    [No Abstract]   [Full Text] [Related]  

  • 8. Risks of testosterone-replacement therapy and recommendations for monitoring.
    Rhoden EL; Morgentaler A
    N Engl J Med; 2004 Jan; 350(5):482-92. PubMed ID: 14749457
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Joint meeting for Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management Advisory Committee (DSARM AC), September 17, 2014.
    Seftel AD
    J Urol; 2015 Feb; 193(2):623-5. PubMed ID: 25617291
    [No Abstract]   [Full Text] [Related]  

  • 10. Testosterone and cardiovascular disease.
    Schooling CM
    Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):202-8. PubMed ID: 24722171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controversy over Cardiovascular Risks of Testosterone Therapy.
    Carter D
    Am J Nurs; 2015 May; 115(5):17. PubMed ID: 25906216
    [No Abstract]   [Full Text] [Related]  

  • 12. A small-scale clinical trial to determine the safety and efficacy of testosterone replacement therapy in hypogonadal men with spinal cord injury.
    Bauman WA; Cirnigliaro CM; La Fountaine MF; Jensen AM; Wecht JM; Kirshblum SC; Spungen AM
    Horm Metab Res; 2011 Jul; 43(8):574-9. PubMed ID: 21717386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Testosterone Prescriptions for Older Men Enrolled in Commercial Insurance and Medicare Advantage.
    Everhart A; Harper K; Jeffery MM; Levin Z; Morden NE; Sankar A; Karaca-Mandic P
    JAMA Netw Open; 2021 Sep; 4(9):e2127349. PubMed ID: 34586370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of testosterone replacement on whole body glucose utilisation and other cardiovascular risk factors in males with idiopathic hypogonadotrophic hypogonadism.
    Tripathy D; Shah P; Lakshmy R; Reddy KS
    Horm Metab Res; 1998 Oct; 30(10):642-5. PubMed ID: 9851674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: risk of myocardial infarction in older men receiving testosterone therapy.
    Dohle GR; Dinkelman-Smit M
    Eur Urol; 2015 Oct; 68(4):739-40. PubMed ID: 26334123
    [No Abstract]   [Full Text] [Related]  

  • 16. Testosterone administration in older men.
    Matsumoto AM
    Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF TESTOSTERONE AND CARDIOVASCULAR RISK.
    Goodman N; Guay A; Dandona P; Dhindsa S; Faiman C; Cunningham GR;
    Endocr Pract; 2015 Sep; 21(9):1066-73. PubMed ID: 26355962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy. More risk than benefit?
    Harv Health Lett; 2000 Jun; 25(8):4-5. PubMed ID: 10810049
    [No Abstract]   [Full Text] [Related]  

  • 19. Association between cholesterol gallstones and testosterone replacement therapy in a patient with primary hypogonadism.
    Squarza S; Rossi UG; Torcia P; Cariati M
    Rev Gastroenterol Mex (Engl Ed); 2018; 83(2):205-207. PubMed ID: 29656844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular and Cerebrovascular Safety of Testosterone Replacement Therapy Among Aging Men with Low Testosterone Levels: A Cohort Study.
    Loo SY; Azoulay L; Nie R; Dell'Aniello S; Yu OHY; Renoux C
    Am J Med; 2019 Sep; 132(9):1069-1077.e4. PubMed ID: 30953635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.